Six-month, prospective, longitudinal, open-Label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement

Mary Jayne Kennedy(Virginia Commonwealth University), Gregory L. Kearns(Texas Christian University), Andrea Gaedigk(Mercy Research), Ned B. Smith(University of Louisville), Daniel A. Davis(University of Louisville), Robin E. Pearce(Children's Mercy Hospital)
Clinical Therapeutics
September 1, 2008
Cited by 7


Related Papers